Human trial
Salidroside primary study · PMID 39601362
50 healthy active young adults in an exploratory short randomized trial of biosynthetic salidroside.
Reported findings. The investigators assessed exercise performance, mood and muscle-damage markers.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Short, exploratory, preparation-specific study. Do not generalize all endpoints or botanical-source preparations to a proven performance benefit.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.